Lasers and energy based devices will lead pigmented lesion treatment sales through 2036 with a 63.0% share in 2026 as the leading product segment. Freckles lead the lesion type segment with a 38.0% share. The market is expected to reach USD 4.50 billion in 2026 and USD 9.53 billion by 2036.